BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23370456)

  • 1. Mechanisms of decrease in fractional exhaled nitric oxide during acute bronchoconstriction.
    Cattoni I; Guarnieri G; Tosetto A; Mason P; Scarpa MC; Saetta M; Maestrelli P
    Chest; 2013 May; 143(5):1269-1276. PubMed ID: 23370456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute changes in bronchoconstriction influences exhaled nitric oxide level.
    Mitsufuji H; Kobayashi H; Imasaki T; Ichikawa T; Kawakami T; Tomita T
    Jpn J Physiol; 2001 Apr; 51(2):151-7. PubMed ID: 11405907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandins E2 and F2alpha reduce exhaled nitric oxide in normal and asthmatic subjects irrespective of airway caliber changes.
    Kharitonov SA; Sapienza MA; Barnes PJ; Chung KF
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1374-8. PubMed ID: 9817681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining axial diffusion of nitric oxide in the lungs using heliox and breath hold.
    Shin HW; Condorelli P; George SC
    J Appl Physiol (1985); 2006 Feb; 100(2):623-30. PubMed ID: 16210445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled nitric oxide levels and airway responsiveness to adenosine 5'-monophosphate in subjects with nasal polyposis.
    Prieto L; Seijas T; Gutiérrez V; Uixera S; Bruno L; López R
    Int Arch Allergy Immunol; 2004 Aug; 134(4):303-9. PubMed ID: 15205562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structural basis of airways hyperresponsiveness in asthma.
    Brown RH; Pearse DB; Pyrgos G; Liu MC; Togias A; Permutt S
    J Appl Physiol (1985); 2006 Jul; 101(1):30-9. PubMed ID: 16469934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway diffusing capacity of nitric oxide and steroid therapy in asthma.
    Shin HW; Rose-Gottron CM; Cooper DM; Newcomb RL; George SC
    J Appl Physiol (1985); 2004 Jan; 96(1):65-75. PubMed ID: 12959957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the bronchial effect of bronchodilating drugs in healthy subjects after methacholine provocation. Salbutamol as a model drug.
    Seppälä OP; Iisalo E
    Eur J Clin Pharmacol; 1990; 39(6):559-63. PubMed ID: 2095342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of methacholine induced bronchoconstriction during drugs and spontaneous resolution.
    Mannino F; Anticoli S; De Luca A; Terzano C
    Allergol Immunopathol (Madr); 1996; 24(2):70-4. PubMed ID: 8933892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Same efficacies of ipratropium and salbutamol in reversing methacholine-induced bronchoconstriction.
    Delpierre S; Guillot C; Badier M
    J Asthma; 2006 Nov; 43(9):679-85. PubMed ID: 17092849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction and recovery phases of methacholine-induced bronchoconstriction using FEV1 according to the degree of bronchial hyperresponsiveness.
    Mannino F; Sposato B; Ricci A; Grasso D; De Clementi F; Mariotta S
    Lung; 2001; 179(3):137-45. PubMed ID: 11891604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway obstruction induced by inhaled acetaldehyde in asthma: repeatability relationship to adenosine 5'-monophosphate responsiveness.
    Prieto L; Gutiérrez V; Cervera A; Liñana J
    J Investig Allergol Clin Immunol; 2002; 12(2):91-8. PubMed ID: 12371536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural basis of airways hyperresponsiveness in asthma.
    Stănescu DC
    J Appl Physiol (1985); 2006 Dec; 101(6):1812; author reply 1813. PubMed ID: 16931560
    [No Abstract]   [Full Text] [Related]  

  • 14. [Measurement of exhaled nitric oxide: methodology].
    Mahut B; Louis B; Delclaux C
    Rev Mal Respir; 2006 Jun; 23(3 Suppl):6S29-6S36. PubMed ID: 16820746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in exhaled nitric oxide immediately after methacholine challenge in asthmatic children.
    Piacentini GL; Bodini A; Peroni DG; Miraglia del Giudice M; Costella S; Boner AL
    Thorax; 2002 Sep; 57(9):771-3. PubMed ID: 12200520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway responsiveness as a direct factor contributing to the dyspnoea perception in asthma.
    Koh YI; Choi IS; Lim H
    Respir Med; 2001 Jun; 95(6):464-70. PubMed ID: 11421503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise-induced bronchoconstriction alters airway nitric oxide exchange in a pattern distinct from spirometry.
    Shin HW; Schwindt CD; Aledia AS; Rose-Gottron CM; Larson JK; Newcomb RL; Cooper DM; George SC
    Am J Physiol Regul Integr Comp Physiol; 2006 Dec; 291(6):R1741-8. PubMed ID: 16840654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The perception of dyspnea after bronchoconstriction and bronchodilation in patients with asthma.
    Weiner P; Beckerman M; Berar-Yanay N; Magadle R
    Respir Med; 2003 Oct; 97(10):1120-5. PubMed ID: 14561019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung mechanics during induced bronchoconstriction.
    Pellegrino R; Wilson O; Jenouri G; Rodarte JR
    J Appl Physiol (1985); 1996 Aug; 81(2):964-75. PubMed ID: 8872669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaled nitric oxide is higher both at day and night in subjects with nocturnal asthma.
    ten Hacken NH; van der Vaart H; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1998 Sep; 158(3):902-7. PubMed ID: 9731024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.